Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen and progesterone effects on transcapillary fluid dynamics.

N S Stachenfeld1, D L Keefe, S F Palter

  • 1The John B. Pierce Laboratory and Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06519, USA. nstach@jbpierce.org

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|September 15, 2001
PubMed
Summary

Estrogen (E(2)) alone did not alter plasma volume (PV) regulation by atrial natriuretic peptide (ANP). However, combined estrogen and progesterone (P(4)) treatment reduced PV loss during ANP infusion by decreasing capillary filtration coefficient (CFC).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications.

Journal of assisted reproduction and genetics·2018
Same author

Peripheral blood telomere content is greater in patients with endometriosis than in controls.

Reproductive sciences (Thousand Oaks, Calif.)·2014
Same author

Efficacy and safety of aliskiren and amlodipine combination therapy in patients with hypertension: a randomized, double-blind, multifactorial study.

Journal of human hypertension·2012
Same author

Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2011
Same author

Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.

Journal of human hypertension·2010
Same author

Aliskiren for geriatric lowering of systolic hypertension: a randomized controlled trial.

Journal of human hypertension·2009

Area of Science:

  • Endocrinology
  • Cardiovascular Physiology
  • Reproductive Biology

Background:

  • Atrial natriuretic peptide (ANP) plays a crucial role in regulating plasma volume (PV) and fluid dynamics.
  • Estrogen (E(2)) and progesterone (P(4)) are key reproductive hormones with known effects on cardiovascular function.
  • The specific impact of E(2) and P(4) on ANP-mediated fluid shifts requires further elucidation.

Purpose of the Study:

  • To investigate the effects of E(2) and P(4) on the control of PV and transcapillary fluid dynamics by ANP.
  • To determine how E(2) administration alone, and in combination with P(4), influences ANP's actions on fluid balance.

Main Methods:

  • Reproductive function was suppressed in 12 women using a GnRH analog.
  • Participants received either E(2) alone or E(2) with P(4) for 4 days.

Related Experiment Videos

  • Plasma volume (PV) and forearm capillary filtration coefficient (CFC) were measured during ANP infusion.

    • Main Results:

    • E(2) treatment alone did not significantly alter preinfusion PV or PV loss during ANP infusion compared to GnRH analog alone.
    • E(2) treatment alone increased CFC during ANP infusion.
    • Combined E(2)-P(4) treatment reduced baseline PV and significantly lowered CFC during ANP infusion.
    • E(2)-P(4) treatment attenuated PV loss during ANP infusion.

    Conclusions:

    • Estrogen (E(2)) alone has minimal impact on ANP's regulation of plasma volume (PV) and transcapillary fluid dynamics.
    • The combination of estrogen and progesterone (E(2)-P(4)) significantly alters fluid dynamics by reducing capillary filtration coefficient (CFC).
    • E(2)-P(4) treatment attenuates plasma volume loss during atrial natriuretic peptide (ANP) infusion, suggesting a protective role in fluid balance regulation.